QuidelOrtho Corporation XNAS: QDEL

QuidelOrtho Corporation Live Share Price Today, Share Analysis and Chart

35.10 -0.06 (-0.17%)

29.02% Fall from 52W High

175.9K XNAS Volume

XNAS 21 Mar, 2025 12:11 PM (EDT)

QuidelOrtho Corporation Key Metrics

Select
All financials are in USD Million and price data in USD
VIEW MORE
Low Financial Strength
27.8 / 100
Mid Valuation
31.7 / 100
Technically Neutral
37.0 / 100
Await Turnaround These stocks are of poor quality, but mid-range financials and valuations. Their performance may improve based on financials, however our advise would be to be careful before buying these stocks. View Similar Embed DVM

QuidelOrtho Corporation Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '263k4k2kActual RevenueAvg. Estimate
Miss

QuidelOrtho Corporation's Revenue was lower than average estimate 2 times in past 3 years

EPS forecast

Current EPS
-30.2
Avg. Estimate
-2.6
Low Estimate
-5.4
High Estimate
-0.7
Current EPS
Avg. Estimate
Hit

EPS is expected to grow by 91.2% in FY25

Consensus Recommendation

8 ANALYST Recommendations
BUY

Created with Highcharts 7.2.21Sell3Hold2Buy2Strong Buy

The consensus recommendation from 8 analysts for QuidelOrtho Corporation is BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

QuidelOrtho Corporation Stock Analysis

QuidelOrtho Corporation stock analysis with key metrics, changes, and trends.

QuidelOrtho Corporation MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$2,782.9 M7.17%negative

Annual Revenue fell 7.17%, in the last year to $2,782.9 M. Its sector's average revenue growth for the last fiscal year was 8.73%.

Annual Net Profit$2,052 M20216.83%negative

Annual Net Profit fell 20,216.83% in the last year to $2,052 M. Its sector's average net profit growth for the last fiscal year was 3.54%.

Price to Earning Ratio-1.15-negative

Price to Earning Ratio is -1.15, which is negative.

Stock Price$35.10-25.98%negative

Stock Price fell 25.98% and underperformed its sector by 31.88% in the past year.

Quarterly Revenue$707.8 M4.69%negative

Quarterly Revenue fell 4.69% YoY to $707.8 M. Its sector's average revenue growth YoY for the quarter was 8.56%.

Quarterly Net profit$178.4 M2648.57%negative

Quarterly Net profit fell 2,648.57% YoY to $178.4 M. Its sector's average net profit growth YoY for the quarter was 27.5%.

Mutual Fund Holding80.59 %5.81%positive

Mutual Fund Holding increased by 5.81% in the last quarter to 80.59.

Promoter Share Holding0.61 %0.02%positive

Promoter Share Holding increased by 0.02% in the most recent quarter to 0.61%.

Institutional Holding108.88 %-0.29%negative

Institutional Holding decreased by 0.29% in the last quarter to 108.88.

VIEW LESS


Loading data..

QuidelOrtho Corporation - Company Profile

What does QuidelOrtho Corporation do?

QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.

QuidelOrtho Corporation Management structure

All Gross Remunerations are in USD
Mr. Douglas C. Bryant
Director, President and Chief Executive Officer
-
2024
Gross Remuneration
Year
Mr. Robert J. Bujarski, J.D.
Chief Operating Officer and Executive Vice President
-
2024
Gross Remuneration
Year
Mr. Michael S. Iskra
Chief Commercial Officer and Executive Vice President
-
2024
Gross Remuneration
Year
Mr. Brian J. Blaser
Director, President and Chief Executive Officer
-
2024
Gross Remuneration
Year
Mr. Philip McLellan
Chief Operations Officer
-
2024
Gross Remuneration
Year
Mr. Joseph M. Busky
Chief Financial Officer and Principal Accounting Officer
-
2024
Gross Remuneration
Year

QuidelOrtho Corporation Board of directors

All Gross Remunerations are in USD
Mr. Douglas C. Bryant
Director, President and Chief Executive Officer
-
2024
Gross Remuneration
Year
Mr. Brian J. Blaser
Director, President and Chief Executive Officer
-
2024
Gross Remuneration
Year
Mr. Robert R. Schmidt
Independent Director
-
2024
Gross Remuneration
Year
Mr. James R. Prutow
Independent Director
-
2024
Gross Remuneration
Year
Mr. Richard Scott Huennekens
Independent Director
-
2024
Gross Remuneration
Year
Mr. John R. Chiminski
Independent Director
-
2024
Gross Remuneration
Year

QuidelOrtho Corporation FAQ

How is QuidelOrtho Corporation today?
QuidelOrtho Corporation today is trading in the red, and is down by -0.17% at 35.10.
QuidelOrtho Corporation is currently trading down -0.17% on an intraday basis. In the past week the stock fell -1.40%. stock has been down -21.72% in the past quarter and fell -25.98% in the past year. You can view this in the overview section.